Showing results (101-110 of 125) with videos related to
Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|April 1, 1980
Diazepam and N-desmethyldiazepam redistribution after heparinP A Routledge, B B Kitchell, T D Bjornsson, et al.British Journal of Clinical Pharmacology|December 1, 1985
A free lignocaine index as a guide to unbound drug concentrationP A Routledge, J D Lazar, A Barchowsky, et al.Journal of Epidemiology and Community Health|October 12, 2000
Community exposures to chemical incidents: development and evaluation of the first environmental public health surveillance system in europeH J Bowen, S R Palmer, H M Fielder, et al.British Journal of Clinical Pharmacology|February 1, 1986
Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamoleA H Watt, M S Bernard, J Webster, et al.British Medical Journal (Clinical Research Ed.)|April 28, 1984
Flexible induction dose regimen for warfarin and prediction of maintenance doseA Fennerty, J Dolben, P Thomas, et al.British Journal of Clinical Pharmacology|November 1, 1985
Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in healthP G Blain, J C Mucklow, M D Rawlins, et al.Circulation|February 1, 1982
Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokineticsS C Hammill, D G Shand, P A Routledge, et al.British Journal of Clinical Pharmacology|July 1, 1989
The effect of theophylline on thyrotoxic tremorD C Buss, D I Phillips, M D Littley, et al.British Journal of Clinical Pharmacology|December 5, 2015
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.European Journal of Clinical Pharmacology|December 18, 1978
Labetalol, a cross-over double blind controlled trialG L Sanders, P A Routledge, J G Rao, et al.Pageof 13